rts logo

Sage Therapeutics Inc (SAGE) Volatility At 6.37%, Should You Add A Position?

Sage Therapeutics Inc (NASDAQ: SAGE) is -49.10% lower on its value in year-to-date trading and has touched a low of $9.76 and a high of $49.74 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SAGE stock was last observed hovering at around $11.47 in the last trading session, with the day’s loss setting it -0.44%.

Currently trading at $11.03, the stock is 0.19% and -5.35% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.71 million and changing -3.84% at the moment leaves the stock -39.89% off its SMA200. SAGE registered -76.69% loss for a year compared to 6-month loss of -56.06%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 4.25% gain in the last 1 month and extending the period to 3 months gives it a -33.23%, and is 1.94% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.37% over the week and 6.44% over the month.

Sage Therapeutics Inc (SAGE) has around 487 employees, a market worth around $663.79M and $91.06M in sales. Profit margin for the company is -552.52%. Distance from 52-week low is 13.01% and -77.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-71.29%).

The EPS is expected to grow by 27.90% this year

The shares outstanding are 60.04M, and float is at 49.49M with Short Float at 15.76%.

Sage Therapeutics Inc (SAGE) Insider Activity

The most recent transaction is an insider purchase by Barrett Elizabeth, the company’s Director. SEC filings show that Barrett Elizabeth bought 2,000 shares of the company’s common stock on Aug 09 ’23 at a price of $18.64 per share for a total of $37279.0. Following the purchase, the insider now owns 3000.0 shares.

Related Posts